aspirin has been researched along with edaravone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J; Liu, W; Sun, Y; Wang, L; Wang, Y; Xu, C; Yu, P; Zhang, Z | 1 |
| Ji, H; Lai, Y; Li, T; Ling, J; Liu, J; Peng, S; Tian, J; Wang, X; Wu, J; Zhang, Y | 1 |
| Hua, K; Huang, Z; Ji, H; Sheng, X; Wang, X; Xu, J; Yang, C; Zhang, Y | 1 |
| Suzuki, Y; Umemura, K | 1 |
| Shinohara, Y | 1 |
| Fukumoto, SY; Fumoto, N; Inoue, A; Kumon, Y; Oda, S; Ohnishi, T; Ohue, S; Watanabe, H | 1 |
| Hong, KW; Lee, JH; Lee, WS; Park, SY | 1 |
| Shima, K | 1 |
| Doi, M; Fukada, Y; Hayashi, M; Murakami, T; Nakashima, K; Nakayasu, H; Suzuki, T; Takeuchi, Y | 1 |
| Matsubara, S; Nagahiro, S; Sasaki, I; Yamasaki, H | 1 |
| Nagasawa, H; Ono, H; Tanaka, H; Yamakawa, T | 1 |
| He, J; Huang, Y; Luo, G; Miao, Z; Wang, X; Wang, Y; Wu, T; Zhao, Z | 1 |
| Hattori, N; Kamo, H; Miyamoto, N; Ogawa, T; Shimo, Y; Tanaka, R; Ueno, Y; Yamashiro, K | 1 |
| Chandra, A; Cheng, Z; Ding, Y; Du, H; Geng, X; Tong, Y; Zhu, H | 1 |
| Abe, K; Hishikawa, N; Ohta, Y; Sasaki, R; Sato, K; Takemoto, M; Yamashita, T | 1 |
3 review(s) available for aspirin and edaravone
| Article | Year |
|---|---|
[The development of new drugs for acute stroke].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Antioxidants; Antipyrine; Aspirin; Clinical Trials as Topic; Drug Design; Edaravone; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Neuroprotective Agents; Recombinant Proteins; Stroke; Tissue Plasminogen Activator | 2000 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
[Advanced medical therapy in patients with acute ischemic stroke].
Topics: Administration, Oral; Anticoagulants; Antipyrine; Arginine; Aspirin; Drug Design; Edaravone; Fibrinolytic Agents; Genomics; Heparin; Humans; Infusions, Intravenous; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator | 2006 |
1 trial(s) available for aspirin and edaravone
| Article | Year |
|---|---|
Low dose concomitant treatment with chlorpromazine and promethazine is safe in acute ischemic stroke.
Topics: Adult; Aged; Aspirin; Atorvastatin; Chlorpromazine; Double-Blind Method; Drug Therapy, Combination; Edaravone; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuroprotective Agents; Platelet Aggregation Inhibitors; Promethazine; Stroke; Vinca Alkaloids | 2019 |
11 other study(ies) available for aspirin and edaravone
| Article | Year |
|---|---|
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
Topics: Animals; Antioxidants; Brain Ischemia; Fibrinolytic Agents; Nitrogen Oxides; Pyrazines; Rats; Stroke; Thrombolytic Therapy | 2008 |
Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one.
Topics: Animals; Antioxidants; Brain; Brain Edema; Brain Infarction; Brain Ischemia; Fibrinolytic Agents; Free Radical Scavengers; Male; Neuroprotective Agents; PC12 Cells; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stereoisomerism; Stroke; Structure-Activity Relationship; Thiophenes | 2012 |
Novel hybrids of 3-n-butylphthalide and edaravone: Design, synthesis and evaluations as potential anti-ischemic stroke agents.
Topics: Animals; Antipyrine; Benzofurans; Cell Line; Drug Design; Edaravone; Free Radical Scavengers; Humans; Hydrogen Peroxide; Neurons; Neuroprotective Agents; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Stroke | 2015 |
[A case of common carotid artery dissection showing remission in short-term].
Topics: Antipyrine; Aortic Dissection; Aspirin; Carotid Artery Diseases; Carotid Artery, Common; Drug Therapy, Combination; Edaravone; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Middle Aged; Remission Induction; Ultrasonography, Interventional | 2005 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Edema; Brain Ischemia; Cerebral Infarction; Clopidogrel; Cyclic AMP Response Element-Binding Protein; Disability Evaluation; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Administration Routes; Edaravone; Functional Laterality; Gene Expression Regulation; Hypoxia, Brain; Male; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Ticlopidine; Tumor Suppressor Proteins | 2005 |
Anterior and posterior inferior cerebellar artery infarction with sudden deafness and vertigo.
Topics: Acute Disease; Antipyrine; Aspirin; Basilar Artery; Brain Infarction; Cerebellar Diseases; Cerebellum; Cochlear Nerve; Deafness; Early Diagnosis; Edaravone; Free Radical Scavengers; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Time Factors; Vertebral Artery; Vertigo; Vestibular Nerve | 2006 |
Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Antipyrine; Aspirin; Carotid Artery, External; Carotid Stenosis; Cerebral Infarction; Combined Modality Therapy; Drug Therapy, Combination; Edaravone; Embolism; Heparin; Humans; Hyperbaric Oxygenation; Intraoperative Complications; Male; Methacrylates; Ophthalmic Artery; Recurrence; Retinal Artery Occlusion; Stents; Ticlopidine | 2009 |
[Case of cardiac tamponade during the treatment of acute cerebral infarction].
Topics: Acute Disease; Adenocarcinoma; Anterior Cerebral Artery; Antipyrine; Aspirin; Cardiac Tamponade; Cerebral Infarction; Drainage; Edaravone; Heparin; Humans; Lung Neoplasms; Magnetic Resonance Angiography; Male; Middle Aged; Neoplasm Invasiveness; Pericardium; Treatment Outcome | 2014 |
The Therapeutic Effect of Stellate Ganglion Block on Facial Nerve Palsy in Patients with Type 2 Diabetes Mellitus.
Topics: Adult; Anesthetics, Local; Antipyrine; Aspirin; Autonomic Nerve Block; Blood Glucose; Dexamethasone; Diabetes Mellitus, Type 2; Edaravone; Facial Nerve Diseases; Facial Paralysis; Female; Free Radical Scavengers; Glucocorticoids; Humans; Lidocaine; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prednisone; Retrospective Studies; Stellate Ganglion; Thiamine; Treatment Outcome; Vinca Alkaloids; Vitamin B 12; Vitamin B Complex | 2015 |
Conjugate Eye Deviation Caused by Upper Medial Medullary Infarction: A Case Report.
Topics: Aged; Antipyrine; Aspirin; Brain Stem Infarctions; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Edaravone; Eye Movements; Female; Fixation, Ocular; Free Radical Scavengers; Humans; Magnetic Resonance Angiography; Medulla Oblongata; Ocular Motility Disorders; Recovery of Function; Treatment Outcome | 2018 |
A Unique Recurrent Stroke Case due to Bilateral Vertebral Artery Dissection with Familial Hirschsprung Disease.
Topics: Adult; Aspirin; Cerebral Angiography; Cerebral Infarction; Cilostazol; Diffusion Magnetic Resonance Imaging; Edaravone; Genetic Predisposition to Disease; Hirschsprung Disease; Humans; Magnetic Resonance Angiography; Male; Neuroprotective Agents; Phenotype; Platelet Aggregation Inhibitors; Recurrence; Treatment Outcome; Vertebral Artery Dissection | 2019 |